Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study

被引:30
作者
Bengtsson, Camilla [1 ]
Kapetanovic, Meliha C. [2 ]
Kallberg, Henrik [1 ]
Sverdrup, Berit [1 ]
Nordmark, Birgitta [3 ]
Klareskog, Lars [3 ]
Alfredsson, Lars [1 ]
机构
[1] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden
[2] Lund Univ, Dept Rheumatol, Inst Clin Sci, Lund, Sweden
[3] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden
基金
英国医学研究理事会;
关键词
ETIOLOGY; DISEASES; GENE;
D O I
10.1136/ard.2010.129908
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate the association between vaccinations in adults and the risk of developing rheumatoid arthritis (RA). Methods Data from the Swedish population-based Epidemiological Investigation of RA case-control study encompassing 1998 incident cases of RA aged 18-70 years and 2252 randomly selected controls matched for age, sex and residency were analysed. Those vaccinated within 5 years before disease onset were compared with those not vaccinated by calculating OR with 95% CI. Results Vaccinations neither increased the risk of RA overall (OR 1.0, 95% CI 0.9 to 1.1) nor the risk of two major subgroups of RA (antibodies to citrullinated peptide-positive (ACPA-positive) and ACPA-negative disease). Furthermore, vaccinations did not increase the risk of RA in smokers or carriers of HLA-DRB1 shared epitope alleles, two groups with established risk factors for RA. Conclusions In this case-control study of incident cases of newly diagnosed RA, no increased risk of RA following immunisation was observed for vaccinations overall or for any specific vaccination. This indicates that immunological provocation of adults with commonly used vaccines in their present form carries no risk of RA. These findings should be implemented among public healthcare providers in order to encourage vaccinations according to recommended national vaccination schedules.
引用
收藏
页码:1831 / 1833
页数:3
相关论文
共 20 条
  • [11] A new model for an etiology of rheumatoid arthritis
    Klareskog, L
    Stolt, P
    Lundberg, K
    Källberg, H
    Bengtsson, C
    Grunewald, J
    Rönnelid, J
    Harris, HE
    Ulfgren, AK
    Rantapää-Dahlqvist, S
    Eklund, A
    Padyukov, L
    Alfredsson, L
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (01): : 38 - 46
  • [12] HLA-DR TYPING BY PCR AMPLIFICATION WITH SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) IN 2 HOURS - AN ALTERNATIVE TO SEROLOGICAL DR TYPING IN CLINICAL-PRACTICE INCLUDING DONOR-RECIPIENT MATCHING IN CADAVERIC TRANSPLANTATION
    OLERUP, O
    ZETTERQUIST, H
    [J]. TISSUE ANTIGENS, 1992, 39 (05): : 225 - 235
  • [13] Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis - A nationwide case-control study in Denmark
    Pedersen, Merete
    Jacobsen, Soren
    Garred, Peter
    Madsen, Hans O.
    Klarlund, Mette
    Svejgaard, Arne
    Pedersen, Bo V.
    Wohlfahrt, Jan
    Frisch, Morten
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1446 - 1453
  • [14] Pope JE, 1998, J RHEUMATOL, V25, P1687
  • [15] Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis:: anti-CP status predicts worse disease activity and greater radiological progression
    Rönnelid, J
    Wick, MC
    Lampa, J
    Lindblad, S
    Nordmark, B
    Klareskog, L
    van Vollenhoven, RF
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (12) : 1744 - 1749
  • [16] Vaccination and rheumatoid arthritis
    Sibilia, J
    Maillefert, JF
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (07) : 575 - 576
  • [17] Responses of the rat immune system to arthritogenic adjuvant oil
    Svelander, L
    Holm, BC
    Bucht, A
    Lorentzen, JC
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (06) : 599 - 605
  • [18] New-onset rheumatoid arthritis after anthrax vaccination
    Vasudev, Monica
    Zacharisen, Michael C.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 97 (01) : 110 - 112
  • [19] Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
    Verstraeten, Thomas
    Descamps, Dominique
    David, Marie-Pierre
    Zahaf, Toufik
    Hardt, Karin
    Izurieta, Patricia
    Dubin, Gary
    Breuer, Thomas
    [J]. VACCINE, 2008, 26 (51) : 6630 - 6638
  • [20] Vial T, 2004, EUR J DERMATOL, V14, P86